Cargando…
Wnt/ß-Catenin: A New Therapeutic Approach to Acute Myeloid Leukemia
Recent studies have shown genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway, thus influencing the initiation and progression of acute myeloid leukemia (AML). Of major importance, these findings may lead to novel treatment strategies exploiting targ...
Autores principales: | Kim, Y., Thanendrarajan, S., Schmidt-Wolf, I. G. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504236/ https://www.ncbi.nlm.nih.gov/pubmed/23213543 http://dx.doi.org/10.4061/2011/428960 |
Ejemplares similares
-
Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia
por: Thanendrarajan, S., et al.
Publicado: (2011) -
Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation
por: Gandillet, Arnaud, et al.
Publicado: (2011) -
“Losing the Brakes”—Suppressed Inhibitors Triggering Uncontrolled Wnt/ß-Catenin Signaling May Provide a Potential Therapeutic Target in Elderly Acute Myeloid Leukemia
por: Elyamany, Ghaleb, et al.
Publicado: (2023) -
Targets of Wnt/ß-Catenin Transcription in Penile Carcinoma
por: Arya, Manit, et al.
Publicado: (2015) -
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia
por: Takam Kamga, Paul, et al.
Publicado: (2020)